We are live on
!
Find out more
PHS
PFM Health Sciences Portfolio holdings
AUM
$1.1B
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
+19.82%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.84B
AUM Growth
+$680M
(+31%)
Cap. Flow
+$205M
Cap. Flow
% of AUM
7.2%
Top 10 Holdings %
Top 10 Hldgs %
32.58%
Holding
110
New
34
Increased
20
Reduced
17
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Universal Health Services
UHS
|
+$55M |
| 2 |
Eli Lilly
LLY
|
+$52.4M |
| 3 |
McKesson
MCK
|
+$51.5M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
+$41.6M |
| 5 |
AbbVie
ABBV
|
+$40.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$114M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$30.6M |
| 3 |
XYZ
Block Inc
XYZ
|
+$29.5M |
| 4 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
+$20.8M |
| 5 |
Microsoft
MSFT
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 79.08% |
| 2 | Financials | 0.38% |
| 3 | Consumer Discretionary | 0% |
| 4 | Industrials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JYAC
76
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
| $5.15M | 0.18% |
+500,000
| New | +$5.09M |
|
|
OSH
77
DELISTED
Oak Street Health, Inc.
OSH
| $4.43M | 0.16% |
+72,451
| New | +$3.8M |
|
78
American Well
AMWL
$231M
| $3.29M | 0.12% |
6,500
| – | – |
|
79
Editas Medicine
EDIT
$445M
| $2.1M | 0.07% |
+29,900
| New | +$1.23M |
|
|
ALNA
80
DELISTED
Allena Pharmaceuticals
ALNA
| $364K | 0.01% |
284,285
| – | – |
|
81
Allogene Therapeutics
ALLO
$687M
| – | – |
-224,266
| Closed | -$8.46M |
|
82
Amazon
AMZN
$2.96T
| – | – |
-106,840
| Closed | -$16.8M |
|
83
Aptiv
APTV
$10.1B
| – | – |
-150,794
| Closed | -$13.8M |
|
84
Deere & Co
DE
$169B
| – | – |
-76,336
| Closed | -$16.9M |
|
85
CALL
Gilead Sciences
GILD
$166B
| – | – |
-350,000
| Closed | -$22.1M |
|
|
HOLX
86
DELISTED
Hologic
HOLX
| – | – |
-272,193
| Closed | -$18.1M |
|
87
Iovance Biotherapeutics
IOVA
$2.69B
| – | – |
-381,990
| Closed | -$15.2M |
|
|
ITOS
88
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-406,467
| Closed | -$10M |
|
89
CALL
Merck
MRK
$316B
| – | – |
-356,320
| Closed | -$28.2M |
|
|
90
Microsoft
MSFT
$3.71T
| – | – |
-95,177
| Closed | -$20M |
|
91
NextEra Energy
NEE
$177B
| – | – |
-188,604
| Closed | -$13.1M |
|
92
NVIDIA
NVDA
$5.38T
| – | – |
-1,036,440
| Closed | -$14M |
|
93
NXP Semiconductors
NXPI
$60.2B
| – | – |
-144,881
| Closed | -$18.1M |
|
94
CALL
Pfizer
PFE
$151B
| – | – |
-976,004
| Closed | -$34M |
|
95
PUT
Invesco QQQ Trust
QQQ
$483B
| – | – |
-381,500
| Closed | -$106M |
|
|
RNAM
96
DELISTED
Avidity Biosciences
RNAM
| – | – |
-441,155
| Closed | -$11M |
|
97
Revvity
RVTY
$12.8B
| – | – |
-147,000
| Closed | -$18.4M |
|
98
Shopify
SHOP
$194B
| – | – |
-94,540
| Closed | -$9.67M |
|
99
Sensata Technologies
ST
$6.84B
| – | – |
-193,585
| Closed | -$8.35M |
|
100
Visa
V
$679B
| – | – |
-43,468
| Closed | -$8.69M |
|
Similar funds
DAM
MAM
DAM
KCM
MIA
YL
SL
PWA
PFM Health Sciences's Q4 2020 Portfolio in Review
As of Q4 2020, PFM Health Sciences held 110 positions worth $2.84B, up 31% from $2.16B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
PFM Health Sciences deployed $205M of net new capital in Q4 2020, opening 34 new positions and adding to 20 existing holdings. Its largest new stake was Universal Health Services: 442,044 shares worth $60.8M.
By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 68% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $30.6M trimmed.
- PFM Health Sciences's largest Q4 2020 buy was Universal Health Services: 442,044 shares worth $60.8M.
- PFM Health Sciences added most to Acadia Pharmaceuticals in Q4 2020, an estimated $41.6M increase.
- PFM Health Sciences's biggest Q4 2020 reduction was BioMarin Pharmaceuticals, cutting an estimated $30.6M.
- PFM Health Sciences fully exited Immunomedics Inc in Q4 2020, selling an estimated $114M.
- PFM Health Sciences's ten largest holdings make up 33% of its $2.84B portfolio in Q4 2020.
- PFM Health Sciences opened 34 new positions and closed 25 in Q4 2020.
- PFM Health Sciences's portfolio value rose 31% quarter-over-quarter to $2.84B.
Based on PFM Health Sciences's 13F filing for Q4 2020, filed 16 Feb 2021.